| ACR50 | mPsARC | ||||
---|---|---|---|---|---|---|
 | Response rate, | Unadjusted odds ratio | Pvalue | Response rate, | Unadjusted odds ratio | Pvalue |
 | n/N (%) | (95% CI) |  | n/N (%) | (95% CI) |  |
History of prior anti-TNF therapy | Â | Â | Â | Â | Â | Â |
   Prior ETN or IFX or both | 25/60 (41.7) | 0.65 (0.37 to 1.13) | 0.130 | 42/59 (71.2) | 0.66 (0.36 to 1.23) | 0.194 |
   No prior ETN/IFXa | 182/348 (52.3) |  |  | 272/345 (78.8) |  |  |